Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKesson
McKinsey
Argus Health
US Department of Justice
Teva

Generated: June 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,188,637

« Back to Dashboard

Which drugs does patent 10,188,637 protect, and when does it expire?

Patent 10,188,637 protects ESBRIET and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 10,188,637
Title:Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same
Abstract: The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.
Inventor(s): Mujumdar; Siddharthya Krishnachandan (Basel, CH)
Assignee: HOFFMANN-LA ROCHE INC. (Little Falls, NJ)
Application Number:15/472,222
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 10,188,637
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,188,637

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-001 Jan 11, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-002 Jan 11, 2017 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-003 Jan 11, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 10,188,637

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 107990 ➤ Try a Free Trial
Australia 2017241530 ➤ Try a Free Trial
Canada 2937365 ➤ Try a Free Trial
China 108883072 ➤ Try a Free Trial
European Patent Office 3435985 ➤ Try a Free Trial
Israel 261745 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
UBS
Johnson and Johnson
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.